Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
118 hedge funds and large institutions have $374M invested in Spectrum Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 15 closing their positions.
17% more capital invested
Capital invested by funds: $319M → $374M (+$55.6M)
13% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 39
3% less funds holding
Funds holding: 122 → 118 (-4)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
34% less call options, than puts
Call options by funds: $2.72M | Put options by funds: $4.14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$24.3M |
| 2 |
Millennium Management
New York
|
+$6.87M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.28M |
| 4 |
PC
PointState Capital
New York
|
+$2.83M |
| 5 |
Retirement Systems of Alabama
Montgomery,
Alabama
|
+$2.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$14.6M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$4.45M |
| 3 |
Morgan Stanley
New York
|
-$2.18M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.41M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$1.41M |
SPPI Hedge Fund Activity: Q3 2013 in Review
118 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2013, worth a combined $374M — up 17% from $319M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of SPPI and 12 opened new positions — a net loss of 3 holders — while 39 trimmed existing stakes and 44 added.
The largest buyer was Deerfield Management, adding an estimated $24.3M. The largest seller was Invesco, cutting an estimated $14.6M.
- 118 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2013, down from 122 in Q2 2013.
- Funds reported $374M of Spectrum Pharmaceuticals Inc stock for Q3 2013, up 17% quarter-over-quarter.
- 12 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2013 and 15 closed out, a net change of -3 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q3 2013 was Deerfield Management, an estimated $24.3M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q3 2013 was Invesco, an estimated $14.6M sold.
Based on aggregated 13F filings for Q3 2013.